U.S. Markets open in 7 hrs 33 mins

NuVasive to Participate in Investor Events in March 2017

SAN DIEGO, March 2, 2017 /PRNewswire/ -- NuVasive, Inc. (NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will participate in the following investor events in March 2017:

  • Cowen 37th Annual Health Care Conference at The Boston Marriott Copley Place in Boston on Tuesday, March 7, 2017 at 10:00 a.m. ET / 7:00 a.m. PT; and
  • Barclays Global Health Care Healthcare Conference 2017 at the Loews Miami Beach Hotel in Miami on Tuesday, March 14, 2017 at 1:35 p.m. ET / 10:35 a.m. PT.

A live webcast of each presentation will be available online from the Investor Relations page of the Company's website at nuvasive.com, and replays of the presentation will remain available on the website for 30 days after the applicable live webcast.

About NuVasive
NuVasive, Inc. (NUVA) is a world leader in minimally invasive, procedurally-integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes. NuVasive's highly differentiated, procedurally-integrated solutions include access instruments, implantable hardware and software systems for surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. With $962 million in revenues (2016), NuVasive has an approximate 2,300 person workforce in more than 40 countries around the world. For more information, please visit www.nuvasive.com.

Forward-Looking Statements
NuVasive cautions you that statements included in this news release and made during the investor events referenced herein that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products (including the iGA™ platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties more fully described in the Company's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nuvasive-to-participate-in-investor-events-in-march-2017-300417417.html